Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 43.68 Million USD | -32.19% |
| 2022 | 64.42 Million USD | -25.76% |
| 2021 | 86.77 Million USD | -17.04% |
| 2020 | 104.6 Million USD | 249.97% |
| 2019 | 29.88 Million CAD | -12.55% |
| 2018 | 34.17 Million CAD | 54.15% |
| 2017 | 22.17 Million CAD | 25.77% |
| 2016 | 17.62 Million CAD | 15.44% |
| 2015 | 15.26 Million CAD | 938.08% |
| 2014 | 1.47 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 57.32 Million USD | 30.68% |
| 2024 Q2 | 50.02 Million USD | -12.81% |
| 2023 Q3 | 50.44 Million USD | -11.2% |
| 2023 Q2 | 56.8 Million USD | -7.24% |
| 2023 Q1 | 61.24 Million USD | -4.93% |
| 2023 Q4 | 43.68 Million USD | -13.4% |
| 2023 FY | 43.68 Million USD | -32.19% |
| 2022 Q3 | 64.08 Million USD | -12.24% |
| 2022 Q2 | 73.02 Million USD | -9.03% |
| 2022 Q1 | 80.27 Million USD | -7.49% |
| 2022 FY | 64.42 Million USD | -25.76% |
| 2022 Q4 | 64.42 Million USD | 0.53% |
| 2021 Q4 | 86.77 Million USD | -7.26% |
| 2021 Q2 | 95.84 Million USD | -3.94% |
| 2021 Q1 | 99.76 Million USD | -4.62% |
| 2021 Q3 | 93.56 Million USD | -2.37% |
| 2021 FY | 86.77 Million USD | -17.04% |
| 2020 Q1 | 58.29 Million CAD | 95.03% |
| 2020 Q3 | 98.46 Million CAD | 75.1% |
| 2020 Q4 | 104.6 Million USD | 6.24% |
| 2020 FY | 104.6 Million USD | 249.97% |
| 2020 Q2 | 56.23 Million CAD | -3.53% |
| 2019 FY | 29.88 Million CAD | -12.55% |
| 2019 Q3 | 32.41 Million CAD | 12.4% |
| 2019 Q1 | 33.6 Million CAD | -1.66% |
| 2019 Q2 | 28.84 Million CAD | -14.19% |
| 2019 Q4 | 29.88 Million CAD | -7.8% |
| 2018 Q2 | 35.02 Million CAD | -12.77% |
| 2018 Q3 | 38.39 Million CAD | 9.6% |
| 2018 Q4 | 34.17 Million CAD | -10.97% |
| 2018 FY | 34.17 Million CAD | 54.15% |
| 2018 Q1 | 40.15 Million CAD | 81.13% |
| 2017 Q1 | 15.57 Million CAD | -11.67% |
| 2017 Q2 | 12.26 Million CAD | -21.26% |
| 2017 Q4 | 22.17 Million CAD | -12.44% |
| 2017 Q3 | 25.32 Million CAD | 106.53% |
| 2017 FY | 22.17 Million CAD | 25.77% |
| 2016 Q1 | 13.91 Million CAD | -8.89% |
| 2016 Q2 | 11.42 Million CAD | -17.88% |
| 2016 Q4 | 17.62 Million CAD | 92.31% |
| 2016 Q3 | 9.16 Million CAD | -19.77% |
| 2016 FY | 17.62 Million CAD | 15.44% |
| 2015 Q2 | 21.76 Million CAD | 1560.37% |
| 2015 Q1 | 1.31 Million CAD | -23.24% |
| 2015 Q3 | 18.05 Million CAD | -17.04% |
| 2015 Q4 | 15.26 Million CAD | -15.42% |
| 2015 FY | 15.26 Million CAD | 938.08% |
| 2014 FY | 1.47 Million CAD | 0.0% |
| 2014 Q4 | 1.7 Million CAD | 5.0% |
| 2014 Q3 | 1.62 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -39.279% |
| BrainsWay Ltd. | 62.97 Million USD | 30.626% |
| Cerus Corporation | 197.74 Million USD | 77.908% |
| Envoy Medical, Inc. | 7.64 Million USD | -471.811% |
| electroCore, Inc. | 16.38 Million USD | -166.591% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -467.945% |
| IceCure Medical Ltd | 16.41 Million USD | -166.218% |
| Inogen, Inc. | 326.19 Million USD | 86.607% |
| OrthoPediatrics Corp. | 449.58 Million USD | 90.283% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -60.199% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -163.504% |
| MaxCyte, Inc. | 268.27 Million USD | 83.716% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -439.516% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1102.845% |
| Orthofix Medical Inc. | 925.31 Million USD | 95.279% |
| PAVmed Inc | 33.11 Million USD | -31.907% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 69.546% |
| RxSight, Inc. | 182.55 Million USD | 76.069% |
| Sight Sciences, Inc. | 166.65 Million USD | 73.786% |
| SI-BONE, Inc. | 230.42 Million USD | 81.041% |
| TELA Bio, Inc. | 78.04 Million USD | 44.026% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 82.658% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -307.142% |
| Acutus Medical, Inc. | 53.96 Million USD | 19.039% |
| Talis Biomedical Corporation | 98.34 Million USD | 55.576% |
| Spectral AI, Inc. | 10.69 Million USD | -308.589% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 80.02% |
| CVRx, Inc. | 115.22 Million USD | 62.087% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 25.527% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1302.337% |
| Bioventus Inc. | 810.91 Million USD | 94.613% |
| Venus Concept Inc. | 93.65 Million USD | 53.353% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -69.821% |
| LivaNova PLC | 2.42 Billion USD | 98.202% |
| 908 Devices Inc. | 202.98 Million USD | 78.478% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 94.575% |
| Nemaura Medical Inc. | 14.56 Million USD | -199.977% |
| NeuroPace, Inc. | 107.65 Million USD | 59.419% |
| LENSAR, Inc. | 69.58 Million USD | 37.219% |
| Apyx Medical Corporation | 79.24 Million USD | 44.868% |
| Cutera, Inc. | 346.29 Million USD | 87.385% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -3.975% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2329.718% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 83.858% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -2.403% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.845% |
| Axonics, Inc. | 719.92 Million USD | 93.932% |
| Outset Medical, Inc. | 313.8 Million USD | 86.078% |
| IRIDEX Corporation | 34.43 Million USD | -26.862% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 89.206% |
| IRadimed Corporation | 92.15 Million USD | 52.595% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -731.487% |
| INVO Bioscience, Inc. | 20.88 Million USD | -109.148% |
| Telesis Bio, Inc. | 70.41 Million USD | 37.955% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 71.651% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.504% |
| Quipt Home Medical Corp. | 247.4 Million USD | 82.342% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -369.241% |
| Pulmonx Corporation | 178.95 Million USD | 75.588% |
| Dynatronics Corporation | 25.94 Million USD | -68.409% |
| Modular Medical, Inc. | 13.8 Million USD | -216.407% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -307.256% |
| Semler Scientific, Inc. | 78.06 Million USD | 44.039% |
| InMode Ltd. | 863.28 Million USD | 94.94% |
| Bruker Corporation | 4.24 Billion USD | 98.972% |
| Cytosorbents Corporation | 53.26 Million USD | 17.976% |
| DexCom, Inc. | 6.26 Billion USD | 99.303% |
| Align Technology, Inc. | 6.08 Billion USD | 99.282% |
| Viveve Medical, Inc. | 25.91 Million USD | -68.588% |
| ZimVie Inc. | 1.2 Billion USD | 96.376% |
| Movano Inc. | 9.42 Million USD | -363.712% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 91.222% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1102.845% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 25.527% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 95.414% |
| Insulet Corporation | 2.58 Billion USD | 98.312% |
| enVVeno Medical Corporation | 48.63 Million USD | 10.175% |
| Surmodics, Inc. | 185.73 Million USD | 76.479% |
| iCAD, Inc. | 41.41 Million USD | -5.477% |
| Nuwellis, Inc. | 9.77 Million USD | -347.148% |
| Biotricity, Inc. | 5.94 Million USD | -635.135% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 89.914% |
| Aethlon Medical, Inc. | 8.24 Million USD | -429.789% |
| InspireMD, Inc. | 47.64 Million USD | 8.305% |
| PAVmed Inc. | 33.11 Million USD | -31.907% |
| BIOLASE, Inc. | 35.1 Million USD | -24.459% |
| Beyond Air, Inc. | 56.96 Million USD | 23.305% |
| FONAR Corporation | 214.24 Million USD | 79.609% |
| AxoGen, Inc. | 196.82 Million USD | 77.805% |
| Vivani Medical, Inc. | 45.79 Million USD | 4.609% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 84.477% |
| Inari Medical, Inc. | 674.23 Million USD | 93.521% |
| UFP Technologies, Inc. | 404.13 Million USD | 89.19% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -86.705% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -359.706% |
| Tenon Medical, Inc. | 6.34 Million USD | -588.516% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -364.402% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 57.851% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.054% |
| Sintx Technologies, Inc. | 15.36 Million USD | -184.324% |
| NanoVibronix, Inc. | 6.67 Million USD | -554.575% |
| Quanterix Corporation | 425.01 Million USD | 89.721% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -369.241% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 18.688% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.498% |
| TransMedics Group, Inc. | 706.04 Million USD | 93.813% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 30.867% |
| NeuroMetrix, Inc. | 21.42 Million USD | -103.909% |
| Hyperfine, Inc. | 94.19 Million USD | 53.623% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 83.738% |
| Biomerica, Inc. | 9.25 Million USD | -372.081% |
| Bone Biologics Corporation | 3.73 Million USD | -1068.783% |
| AVITA Medical, Inc. | 144.33 Million USD | 69.734% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -797.321% |
| Silk Road Medical, Inc | 265.3 Million USD | 83.534% |